Short-term efficacy and safety of metformin in individuals with type 2 diabetes and mild hepatic impairment: A propensity score-matched real-world study
Diabetes Obes Metab
.
2024 Dec 6.
doi: 10.1111/dom.16108.
Online ahead of print.
Authors
Seunghwan Baek
1
,
Jongseok Park
2
3
,
Jae-Yong Chung
1
,
Soo Heon Kwak
3
,
Seonghae Yoon
1
Affiliations
1
Department of Clinical Pharmacology and Therapeutics, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
2
Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
3
Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Hospital, Seoul, Republic of Korea.
PMID:
39639838
DOI:
10.1111/dom.16108
No abstract available
Keywords:
effectiveness; liver; metformin; real‐world evidence; type 2 diabetes.
Grants and funding
23212MFDS202/Ministry of Food and Drug Safety
02-2022-0023/Seoul National University Bundang Hospital Research Fund